greeksoup/ stock research

UnitedHealth Group (UNH) FY2024 results: revenue $400.3 billion, up 7.7% on the year

UnitedHealth Group Inc. (UNH) reported revenue of $400.3 billion for fiscal 2024, the year ended 31 December 2024, up 7.7% on the year before. Net income was $14.4 billion, down 35.6%, and diluted earnings per share $15.51. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2025.

Revenue
$400.3 billion
+7.7% on the year
FY2017FY2024
Operating margin
8.1%
8.7% a year earlier
FY2017FY2024
Net income
$14.4 billion
-35.6% on the year
FY2017FY2024
Diluted EPS
$15.51
-35.0% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue400,278371,622324,162+7.7%
Cost of revenue46,69438,77033,703+20.4%
Gross profit353,584332,852290,459+6.2%
Gross margin88.3%89.6%89.6%
Selling, general and administrative53,01354,62847,782-3.0%
Operating income32,28732,35828,435-0.2%
Operating margin8.1%8.7%8.8%
Interest expense3,9063,2462,092+20.3%
Pre-tax income20,07129,11226,343-31.1%
Income tax4,8295,9685,704-19.1%
Effective tax rate24.1%20.5%21.7%
Net income14,40522,38120,120-35.6%
Net margin3.6%6.0%6.2%
Diluted EPS$15.51$23.86$21.18-35.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow24,20429,06826,206-16.7%
Capital expenditure3,4993,3862,802+3.3%
Free cash flow20,70525,68223,404-19.4%
Free cash flow margin5.2%6.9%7.2%
Cash from investing-20,527-15,574-28,476
Cash from financing-3,512-11,5294,226
Depreciation and amortisation4,0993,9723,400+3.2%
Share-based compensation1,0181,059925-3.9%
Buybacks9,0008,0007,000+12.5%
Dividends paid7,5336,7615,991+11.4%
Dividend per share$8.18$7.29$6.40+12.2%
Diluted shares, weighted929m938m950m-1.0%
Shares outstanding at period end915m924m934m-1.0%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity98,26894,42181,450+4.1%
Redeemable equity4,3234,4984,897-3.9%
Debt76,90462,53757,623+23.0%
Other liabilities118,783112,264101,735+5.8%
Total liabilities and equity298,278273,720245,705+9.0%
Fixed assets10,55311,45010,128-7.8%
Goodwill106,734103,73293,352+2.9%
Intangible assets23,26815,19414,401+53.1%
Investments56,15551,81048,274+8.4%
Cash and equivalents25,31225,42723,365-0.5%
Receivables22,36521,27617,681+5.1%
Inventory3,8002,8003,500+35.7%
Other assets50,09142,03135,004+19.2%
Total assets298,278273,720245,705+9.0%

10-K for the year ended 31 December 2024, filed 27 February 2025: the filing.